COMPLEX CHALLENGES. EXCEPTIONAL SOLUTIONS. Trademark

Trademark Overview


On Friday, August 11, 2017, a trademark application was filed for COMPLEX CHALLENGES. EXCEPTIONAL SOLUTIONS. with the United States Patent and Trademark Office. The USPTO has given the COMPLEX CHALLENGES. EXCEPTIONAL SOLUTIONS. trademark a serial number of 87565901. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, June 3, 2024. This trademark is owned by ProPharma Group Holdings, LLC. The COMPLEX CHALLENGES. EXCEPTIONAL SOLUTIONS. trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Business information and business consulting services, namely, providing business advisory services to identify, screen, and select contract manufacturing organizations to contract and build medical and pharmaceutical products and devices; providing business advisory services to health care providers, namely, designing the administrative, financial and clinical workflows associated with value-based healthcare delivery models; providing business assistance to healthcare providers in the field of enabling communication and collaboration for the purpose of developing, implementing and evaluating patient care plans; Business services, namely, tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for business purposes

Regulatory compliance consulting in the pharmaceutical, biotechnology, and medical fields; Regulatory compliance consulting in the fields of drug and device development and manufacturing; Tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for legal or regulatory compliance purposes; Tracking and monitoring regulatory requirements in the field of drug and device development and manufacturing for regulatory compliance purposes

Consulting services in the medical, pharmaceutical, and biotechnology fields; providing medical and pharmaceutical information services, namely, drug interaction call centers, adverse event reporting services for drugs and medical devices and product compliant reporting services for drugs and medical device; medical information; providing medical information, consultancy and advisory services; health care consulting, namely, aggregating clinical, claims, socioeconomic and behavioral health data for the purpose of improving healthcare providers' evaluation of health conditions and health risks with individual patients, cohorts of patients, and populations; health care consulting, namely, assessing patient and population health profiles using evidence-based medical guidelines for the purpose of improving healthcare provider treatment decisions at the point of care; providing information over a global computer network in the field of health care; maintaining files and records concerning t...

Providing quality assurance services in the medical, pharmaceutical, and biotechnology fields; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the medical, pharmaceutical, and biotechnology fields; Testing, analysis, and evaluation of medical, pharmaceutical, and biotechnology services to assure compliance with industry standards; Tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for quality control purposes
complex challenges. exceptional solutions.

General Information


Serial Number87565901
Word MarkCOMPLEX CHALLENGES. EXCEPTIONAL SOLUTIONS.
Filing DateFriday, August 11, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, June 3, 2024
Registration Number5602592
Registration DateTuesday, November 6, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2018

Trademark Statements


Goods and ServicesBusiness information and business consulting services, namely, providing business advisory services to identify, screen, and select contract manufacturing organizations to contract and build medical and pharmaceutical products and devices; providing business advisory services to health care providers, namely, designing the administrative, financial and clinical workflows associated with value-based healthcare delivery models; providing business assistance to healthcare providers in the field of enabling communication and collaboration for the purpose of developing, implementing and evaluating patient care plans; Business services, namely, tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for business purposes
Goods and ServicesRegulatory compliance consulting in the pharmaceutical, biotechnology, and medical fields; Regulatory compliance consulting in the fields of drug and device development and manufacturing; Tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for legal or regulatory compliance purposes; Tracking and monitoring regulatory requirements in the field of drug and device development and manufacturing for regulatory compliance purposes
Goods and ServicesConsulting services in the medical, pharmaceutical, and biotechnology fields; providing medical and pharmaceutical information services, namely, drug interaction call centers, adverse event reporting services for drugs and medical devices and product compliant reporting services for drugs and medical device; medical information; providing medical information, consultancy and advisory services; health care consulting, namely, aggregating clinical, claims, socioeconomic and behavioral health data for the purpose of improving healthcare providers' evaluation of health conditions and health risks with individual patients, cohorts of patients, and populations; health care consulting, namely, assessing patient and population health profiles using evidence-based medical guidelines for the purpose of improving healthcare provider treatment decisions at the point of care; providing information over a global computer network in the field of health care; maintaining files and records concerning the medical condition of individuals; maintaining personal medical history records and files; providing medical information, consultancy, and advisory services, namely, providing healthcare providers, insurance companies, and healthcare product manufacturers with information and statistics regarding patient medication intake, schedule compliance, and health status
Goods and ServicesProviding quality assurance services in the medical, pharmaceutical, and biotechnology fields; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the medical, pharmaceutical, and biotechnology fields; Testing, analysis, and evaluation of medical, pharmaceutical, and biotechnology services to assure compliance with industry standards; Tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for quality control purposes

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, August 18, 2017
Primary Code035
First Use Anywhere DateThursday, July 20, 2017
First Use In Commerce DateMonday, January 1, 2018

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 18, 2017
Primary Code042
First Use Anywhere DateThursday, July 20, 2017
First Use In Commerce DateMonday, January 1, 2018

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 18, 2017
Primary Code044
First Use Anywhere DateThursday, July 20, 2017
First Use In Commerce DateMonday, January 1, 2018

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 18, 2017
Primary Code045
First Use Anywhere DateThursday, July 20, 2017
First Use In Commerce DateMonday, January 1, 2018

Trademark Owner History


Party NameProPharma Group Holdings, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressOverland Park, KS 66210

Party NameProPharma Group Holdings, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressOverland Park, KS 66210

Party NameProPharma Group Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressOverland Park, KS 66210

Trademark Events


Event DateEvent Description
Tuesday, August 15, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, August 15, 2017NEW APPLICATION ENTERED
Friday, August 18, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 31, 2017ASSIGNED TO LIE
Thursday, August 31, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 28, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, December 30, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 14, 2017ASSIGNED TO EXAMINER
Wednesday, November 15, 2017NON-FINAL ACTION WRITTEN
Wednesday, November 15, 2017NON-FINAL ACTION E-MAILED
Wednesday, November 15, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 21, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 30, 2017EXAMINERS AMENDMENT E-MAILED
Saturday, December 30, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 3, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, December 30, 2017EXAMINER'S AMENDMENT ENTERED
Saturday, December 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 17, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 6, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, November 27, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, June 3, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 3, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, June 3, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, November 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, August 9, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, August 9, 2018USE AMENDMENT FILED
Friday, September 7, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, September 8, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, October 1, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 2, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 6, 2018REGISTERED-PRINCIPAL REGISTER